bioRxivSystems BiologyPreprint
AP-1 Mediates Cellular Adaptation and Memory Formation During Therapy Resistance
Jingxin LiiD, Pavithran T. RavindraniD, Aoife O’FarrelliD, Gianna T. BuschiD, Ryan H. BoeiD, Zijian NiuiD, Sean WooiD, Margaret C. DunaginiD, Naveen JainiD, Yogesh GoyaliD, Kavitha SarmaiD, Meenhard HerlyniD, Arjun RajiD
Abstract
Cellular responses to environmental stimuli are typically thought to be governed by genetically encoded programs. We demonstrate that melanoma cells can form and maintain cellular memories during the acquisition of therapy resistance that exhibit characteristics of cellular learning and are dependent on the transcription factor AP-1. We show that cells exposed to a low dose of therapy adapt to become resistant to a high dose, demonstrating that resistance was not purely selective. The application of therapy itself results in the encoding of transient gene expression into cellular memory and that this encoding occurs for both transiently induced and probabilistically arising expression. Chromatin accessibility showed concomitant persistence. A two-color AP-1 reporter system showed that these memories are encoded in cis, constituting an example of activating cis epigenetics. Our findings establish the formation and maintenance of cellular memories as a critical aspect of gene regulation during the development of therapy resistance.
- organism: human
- assay: bulk RNA-seq
- research focus: gene regulatory network inference
- research focus: differential expression
- approach: statistical model
- Citations
- 13
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Disrupting cellular memory to overcome drug resistance
Guillaume Harmange, Raúl A. Reyes Hueros, … Sydney M. Shaffer·Nature CommunicationsPeer-reviewed·Nov 6, 2023
- Drug-induced adaptation along a resistance continuum in cancer cells
G. S. Franca, M. Baron, … I. Yanai·bioRxiv·Jun 21, 2022
- Transient cell-in-cell formation underlies tumor resistance to immunotherapy
A. Gutwillig, N. Santana-Magal, … Y. Carmi·bioRxiv·Sep 10, 2020
- A neural crest stem cell-like state drives nongenetic resistance to targeted therapy in melanoma
O. Marin-Bejar, A. Rogiers, … J.-C. Marine·bioRxiv·Dec 15, 2020
- AP-1 transcription factor network explains diverse patterns of cellular plasticity in melanoma cells
Natacha Comandante-Lou, Douglas G. Baumann, Mohammad Fallahi‐Sichani·Cell ReportsPeer-reviewed·Aug 1, 2022
- Rapidly induced drug adaptation mediates escape from BRAF inhibition in single melanoma cells
c. yang, C. Tian, … S. L. Spencer·bioRxiv·Mar 15, 2020